EUVIMEDEUVIMED entdecken
Crossref

Effect of Diminazene Aceturate, an ACE2 activator, on platelet CD40L signaling induced glial activation in rat model of hypertension

Priya Tiwari, Mona Elgazzaz, Eric Lazartigues, Kashif Hanif

International Immunopharmacology · 2024-09 · 139 · 112654

DOI: 10.1016/j.intimp.2024.112654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-09. Verfasst von Priya Tiwari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow 226031, U.P., India; Academy of Scientific and Innovative Research (AcSIR), G…. Hauptthemen laut MEDLINE: Diminazene, Angiotensin-Converting Enzyme 2, Signal Transduction, Hypertension. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Government of India Department of Biotechnology, Central Drug Research Institute, Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension causes platelet activation and adhesion in the brain resulting in glial activation and neuroinflammation. Further, activation of Angiotensin-Converting Enzyme 2/Angiotensin (1-7)/Mas Receptor (ACE2/Ang (1-7)/MasR) axis of central Renin-Angiotensin System (RAS), is known to reduce glial activation and neuroinflammation, thereby exhibiting anti-hypertensive and anti-neuroinflammatory properties. Therefore, in the present study, the role of ACE2/Ang (1-7)/MasR axis was studied on platelet-induced glial activation and neuroinflammation using Diminazene Aceturate (DIZE), an ACE2 activator, in astrocytes and microglial cells as well as in rat model of hypertension. We found that the ACE2 activator DIZE, independently of its BP-lowering properties, efficiently prevented hypertension-induced glial activation, neuroinflammation, and platelet CD40-CD40L signaling via upregulation of ACE2/Ang (1-7)/MasR axis. Further, DIZE decreased platelet deposition in the brain by reducing the expression of adhesion molecules on the brain endothelium. Activation of ACE2 also reduced hypertension-induced endothelial dysfunction by increasing eNOS bioavailability. Interestingly, platelets isolated from hypertensive rats or activated with ADP had significantly increased sCD40L levels and induced significantly more glial activation than platelets from DIZE treated group. Therefore, injection of DIZE pre-treated ADP-activated platelets into normotensive rats strongly reduced glial activation compared to ADP-treated platelets. Moreover, CD40L-induced glial activation, CD40 expression, and NFкB-NLRP3 inflammatory signaling are reversed by DIZE. Furthermore, the beneficial effects of ACE2 activation, DIZE was found to be significantly blocked by MLN4760 (ACE2 inhibitor) as well as A779 (MasR antagonist) treatments. Hence, our study demonstrated that ACE2 activation reduced the platelet CD40-CD40L induced glial activation and neuroinflammation, hence imparted neuroprotection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiminazeneAngiotensin-Converting Enzyme 2Signal TransductionHypertensionCD40 LigandDisease Models, AnimalPeptidyl-Dipeptidase AAnimalsMaleRatsBlood PlateletsAstrocytesProto-Oncogene MasNeurogliaPeptide FragmentsAngiotensin ICells, CulturedMicrogliaBrainRats, WistarRenin-Angiotensin SystemReceptors, G-Protein-CoupledCD40 AntigensHumansPlatelet ActivationAntihypertensive Agents

Stichwörter der Autor:innen

Angiotensin Converting Enzyme 2CD40LHypertensionNeuroinflammationPlatelet activation

Substanzen

Diminazenediminazene aceturateAngiotensin-Converting Enzyme 2Ace2 protein, ratCD40 LigandPeptidyl-Dipeptidase AProto-Oncogene MasPeptide Fragmentsangiotensin I (1-7)Angiotensin I

Autor:innen und Institutionen

  • Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow 226031, U.P., India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
  • Department of Pharmacology & Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
  • Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow 226031, U.P., India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. Electronic address: k_hanif@cdri.res.in.

Förderung

  • Government of India Department of Biotechnology
  • Central Drug Research Institute
  • Council of Scientific and Industrial Research, India
  • University Grants Commission

Zitieren

APA

Tiwari, P., Elgazzaz, M., Lazartigues, E., & Hanif, K. (2024). Effect of Diminazene Aceturate, an ACE2 activator, on platelet CD40L signaling induced glial activation in rat model of hypertension. International Immunopharmacology, 139, 112654. https://doi.org/10.1016/j.intimp.2024.112654

Vancouver

Tiwari P, Elgazzaz M, Lazartigues E, Hanif K. Effect of Diminazene Aceturate, an ACE2 activator, on platelet CD40L signaling induced glial activation in rat model of hypertension. International Immunopharmacology. 2024;139:112654. doi:10.1016/j.intimp.2024.112654

BibTeX
@article{Tiwari2024,
  author = {Tiwari, Priya and Elgazzaz, Mona and Lazartigues, Eric and Hanif, Kashif},
  title = {Effect of Diminazene Aceturate, an ACE2 activator, on platelet CD40L signaling induced glial activation in rat model of hypertension},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {139},
  pages = {112654},
  doi = {10.1016/j.intimp.2024.112654}
}
Kostenlos starten →